Bell Investment Advisors’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-36
Closed -$691 1910
2026
Q1
$691 Hold
36
﹤0.01% 1634
2025
Q4
$792 Buy
36
+32
+800% +$578 ﹤0.01% 1604
2025
Q3
$49 Sell
4
-32
-89% -$433 ﹤0.01% 1869
2025
Q2
$672 Hold
36
﹤0.01% 1693
2025
Q1
$690 Hold
36
﹤0.01% 1664
2024
Q4
$1.3K Hold
36
﹤0.01% 1500
2024
Q3
$1.53K Hold
36
﹤0.01% 1452
2024
Q2
$1.45K Hold
36
﹤0.01% 1479
2024
Q1
$1.27K Hold
36
﹤0.01% 1529
2023
Q4
$1.06K Buy
36
+32
+800% +$664 ﹤0.01% 1573
2023
Q3
$84 Hold
4
﹤0.01% 1918
2023
Q2
$99 Sell
4
-38
-90% -$1.22K ﹤0.01% 1912
2023
Q1
$1.71K Sell
42
-11
-21% -$455 ﹤0.01% 1342
2022
Q4
$2.38K Buy
53
+19
+56% +$860 ﹤0.01% 1193
2022
Q3
$2K Buy
34
+13
+62% +$713 ﹤0.01% 1227
2022
Q2
$1K Buy
+21
New +$1.72K ﹤0.01% 1624
2021
Q4
$5K Sell
36
-6
-14% -$810 ﹤0.01% 802
2021
Q3
$5K Buy
+42
New +$4.63K ﹤0.01% 740

Other funds holding TNDM

Bell Investment Advisors's TNDM Position: Q2 2026 in Review

Bell Investment Advisors sold out of Tandem Diabetes Care (TNDM) in Q2 2026, closing a stake of 36 shares — an estimated $691 sold.

Bell Investment Advisors first reported a position in TNDM in Q3 2021 and held it in 18 quarters. The position peaked at $5K in Q4 2021. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Bell Investment Advisors reported no remaining Tandem Diabetes Care position as of Q2 2026 after selling out during the quarter.
  • Bell Investment Advisors sold 36 Tandem Diabetes Care shares in Q2 2026, an estimated $691.
  • Bell Investment Advisors first reported a position in Tandem Diabetes Care in Q3 2021 and held it in 18 quarters.
  • Bell Investment Advisors's Tandem Diabetes Care position peaked at $5K in Q4 2021.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Bell Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.